Rituximab-responsive nephrotic syndrome due to minimal change disease in systemic lupus erythematosus

J Clin Rheumatol. 2012 Jun;18(4):199-202. doi: 10.1097/RHU.0b013e3182582477.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Antibodies, Monoclonal, Murine-Derived / administration & dosage*
  • Antirheumatic Agents / administration & dosage*
  • Diuretics / administration & dosage
  • Drug Therapy, Combination
  • Female
  • Furosemide / administration & dosage
  • Glucocorticoids / administration & dosage
  • Humans
  • Hydroxychloroquine / administration & dosage
  • Lupus Erythematosus, Systemic / complications*
  • Nephrosis, Lipoid / drug therapy*
  • Nephrosis, Lipoid / etiology
  • Nephrotic Syndrome / drug therapy*
  • Nephrotic Syndrome / etiology
  • Prednisone / administration & dosage
  • Rituximab
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal, Murine-Derived
  • Antirheumatic Agents
  • Diuretics
  • Glucocorticoids
  • Rituximab
  • Hydroxychloroquine
  • Furosemide
  • Prednisone